Interventional Radiology Market Size, Share, Growth, and Industry Analysis, By Type (MRI Systems, Ultrasound Imaging Systems, CT Scanners, Angiography Systems, Fluoroscopy Systems, and Biopsy Devices), By Application (Angiography, Balloon Angioplasty, Embolization, Biopsy, Vertebroplasty-Kyphoplasty, and RF Ablation), and Regional Insights and Forecast From 2026-2035

•   
•   
  

  Download Free Sample to learn more about this report

    

INTERVENTIONAL RADIOLOGY MARKET OVERVIEW

In 2026, the global Interventional Radiology Market is estimated at USD 25.08 Billion. With consistent expansion, the market is projected to attain USD 73.44 Billion by 2035. The market is forecast to grow at a CAGR of 12.67% over the period from 2026 to 2035.

The Interventional Radiology Market focuses on minimally invasive procedures performed under image guidance using angiography, computed tomography, ultrasound, and magnetic resonance imaging. More than 78% of vascular interventions are now completed through minimally invasive techniques, reducing hospital stays by approximately 45% compared with conventional surgery. Approximately 69% of tertiary hospitals have dedicated interventional radiology suites equipped with advanced imaging systems. Over 64% of oncology centers utilize image-guided interventional procedures for tumor diagnosis and treatment. Catheter-based interventions account for nearly 57% of all interventional radiology procedures, while image-guided biopsies contribute approximately 21% of procedural volume worldwide.

The United States represents one of the largest Interventional Radiology Market participants because of advanced healthcare infrastructure and widespread adoption of minimally invasive procedures. More than 6,100 hospitals operate across the country, with approximately 74% of large hospitals maintaining dedicated interventional radiology departments. Nearly 82% of cardiovascular centers perform catheter-based image-guided procedures. Approximately 68% of cancer hospitals utilize interventional radiology for biopsy, embolization, and tumor ablation treatments. Around 71% of peripheral vascular disease interventions are completed using minimally invasive image-guided techniques, while outpatient interventional procedures have increased by approximately 36% due to shorter recovery periods and lower complication rates.

KEY FINDINGS

LATEST TRENDS

Technological advances and rising demand drive market growth

The Interventional Radiology Market is rapidly evolving with the adoption of advanced imaging systems, robotic assistance, artificial intelligence, and hybrid operating rooms. Approximately 66% of newly installed angiography systems incorporate three-dimensional imaging capabilities that improve procedural precision. Artificial intelligence-assisted image processing has been implemented in nearly 55% of advanced interventional radiology platforms, reducing image reconstruction time by approximately 32%. Robotic-assisted catheter navigation systems are now utilized by approximately 38% of specialized cardiovascular centers, improving catheter positioning accuracy during complex procedures.

Minimally invasive oncology treatments continue to expand globally. Approximately 64% of liver tumor interventions are now performed using image-guided embolization or ablation techniques instead of conventional surgery. Ultrasound-guided biopsy procedures account for nearly 61% of soft tissue diagnostic interventions due to improved patient safety and shorter recovery times. Around 58% of newly developed fluoroscopy systems feature lower radiation exposure technologies while maintaining high-resolution imaging quality. Hybrid operating rooms equipped with integrated CT and angiography systems are available in approximately 47% of tertiary hospitals, supporting multidisciplinary image-guided interventions across cardiovascular, neurological, orthopedic, and oncology specialties.

•   
•   
  

  Download Free Sample to learn more about this report

    

INTERVENTIONAL RADIOLOGY MARKET SEGMENTATION

By Type

Based on Type, the global market can be categorized into MRI Systems, Ultrasound Imaging Systems, CT Scanners, Angiography Systems, Fluoroscopy Systems, and Biopsy Devices

• MRI Systems: MRI systems account for approximately 14% of the Interventional Radiology Market applications. Approximately 63% of neurological and musculoskeletal interventions utilize MRI for detailed soft tissue visualization. High-field MRI systems provide superior anatomical resolution during pre-procedural planning. Around 48% of complex oncology interventions incorporate MRI imaging to improve lesion localization. Continuous technological improvements support faster image acquisition and enhanced treatment planning accuracy.

• Ultrasound Imaging Systems: Ultrasound imaging systems contribute approximately 17% of application demand because they provide real-time imaging without ionizing radiation. Nearly 74% of image-guided biopsies are performed using ultrasound guidance. Around 69% of vascular access procedures rely on ultrasound visualization to improve placement accuracy. Portable ultrasound systems are utilized in approximately 57% of emergency interventional procedures. High-frequency probes continue improving visualization of superficial anatomical structures and vascular pathways.

• CT Scanners: CT scanners account for approximately 18% of the Interventional Radiology Market applications. Approximately 72% of lung biopsies and 66% of abdominal tumor interventions utilize CT guidance because of high spatial resolution. Advanced multidetector CT systems improve procedural planning while reducing scanning time by approximately 29%. Three-dimensional CT reconstruction enhances anatomical visualization during complex interventions involving the liver, kidneys, lungs, and spine.

• Angiography Systems: Angiography systems represent approximately 26% of application demand, making them the leading imaging platform within the Interventional Radiology Market. Nearly 83% of cardiovascular interventions utilize digital angiography for real-time vascular imaging. Flat-panel detector technology improves visualization while reducing radiation exposure by approximately 20%. Around 54% of newly installed angiography systems integrate artificial intelligence-assisted image optimization for enhanced procedural efficiency.

• Fluoroscopy Systems: Fluoroscopy systems contribute approximately 12% of market applications and remain essential for continuous real-time procedural guidance. Approximately 79% of catheter-based interventions require fluoroscopic visualization. Modern low-dose fluoroscopy systems reduce radiation exposure by approximately 28% while maintaining high image quality. Around 58% of orthopedic and spinal interventions depend on fluoroscopic guidance for accurate device placement and treatment monitoring.

• Biopsy Devices: Biopsy devices account for approximately 8% of application demand within the Interventional Radiology Market. Nearly 68% of image-guided tissue sampling procedures utilize automated core biopsy devices. Around 61% of oncology diagnostic pathways incorporate minimally invasive biopsy techniques before treatment planning. Vacuum-assisted biopsy systems improve tissue collection efficiency while reducing repeat procedures. Continuous improvements in needle design support greater precision and patient safety.

• Others: The Others segment contributes approximately 5% of the Interventional Radiology Market and includes navigation software, guidewires, catheters, contrast delivery systems, and image fusion technologies. Approximately 52% of advanced interventional centers utilize image fusion platforms combining CT, MRI, and ultrasound data during complex procedures. Navigation systems improve catheter placement accuracy by approximately 26%, while advanced guidewire technologies support safer access through complex vascular anatomy. Continuous innovation in accessory devices enhances procedural efficiency and clinical outcomes.

By Application

Based on application, the global market can be categorized into Angiography, Balloon Angioplasty, Embolization, Biopsy, Vertebroplasty-Kyphoplasty, and RF Ablation

• Angiography: Angiography represents approximately 28% of the Interventional Radiology Market and remains the largest procedural segment due to its widespread application in cardiovascular and peripheral vascular disease diagnosis. Nearly 82% of catheter-based vascular procedures are performed using angiographic imaging guidance. Around 74% of tertiary cardiac centers operate dedicated digital angiography suites. Advanced flat-panel detector technology improves image quality while reducing radiation exposure by approximately 22%. Three-dimensional angiography is now utilized in nearly 48% of complex vascular interventions, supporting improved procedural precision and treatment planning for cardiovascular specialists.

• Balloon Angioplasty: Balloon angioplasty accounts for approximately 22% of the Interventional Radiology Market because of increasing treatment of coronary artery disease and peripheral arterial disease. Approximately 79% of angioplasty procedures are completed using minimally invasive catheter techniques. Around 68% of patients undergoing balloon angioplasty are discharged within 24 hours after treatment. Drug-coated balloon technologies are utilized in nearly 39% of peripheral vascular interventions, improving vessel patency. Imaging-guided angioplasty continues to reduce recovery time by approximately 43% compared with open surgical vascular procedures.

• Embolization: Embolization contributes approximately 18% of the Interventional Radiology Market and is widely used for oncology, uterine fibroids, gastrointestinal bleeding, and vascular malformations. Approximately 64% of liver cancer interventions involve transarterial embolization procedures. Around 58% of uterine fibroid treatments utilize uterine artery embolization as a minimally invasive alternative to surgery. Image-guided embolization achieves technical success rates exceeding 90% in many vascular applications. Advanced embolic materials continue improving treatment precision while reducing post-procedure complications and hospitalization requirements.

• Biopsy: Biopsy procedures account for approximately 15% of the Interventional Radiology Market. Nearly 71% of soft tissue biopsies are performed under ultrasound or CT guidance to improve diagnostic accuracy and reduce procedural complications. Around 62% of oncology diagnostic procedures utilize image-guided needle biopsy techniques. Minimally invasive biopsy procedures reduce recovery periods by approximately 47% compared with surgical biopsy methods. Real-time imaging guidance improves tissue sampling accuracy while minimizing injury to surrounding anatomical structures.

• Vertebroplasty-Kyphoplasty: Vertebroplasty-kyphoplasty represents approximately 7% of the Interventional Radiology Market, primarily supporting treatment of osteoporotic vertebral compression fractures. Approximately 76% of treated patients report significant pain reduction following image-guided vertebral augmentation procedures. Around 59% of procedures are performed in outpatient settings with shorter recovery periods than conventional spinal surgery. Fluoroscopic imaging ensures accurate bone cement placement while reducing procedural risks. Increasing prevalence of osteoporosis among elderly populations continues supporting demand for vertebral stabilization procedures.

• RF Ablation: Radiofrequency ablation accounts for approximately 10% of the Interventional Radiology Market and is extensively applied in oncology, cardiology, and pain management. Approximately 67% of liver tumor ablation procedures utilize radiofrequency energy under ultrasound or CT guidance. Around 61% of renal tumor ablations are completed using minimally invasive techniques. Advanced temperature-controlled RF systems improve treatment precision while preserving surrounding healthy tissue. Image-guided RF ablation reduces hospitalization by approximately 44% compared with conventional surgical tumor removal in selected patients.

MARKET DYNAMICS

Driving Factor

Rising demand for minimally invasive image-guided procedures.

The increasing preference for minimally invasive procedures remains the primary growth driver for the Interventional Radiology Market. Approximately 78% of vascular interventions are performed using catheter-based image-guided techniques because they reduce surgical trauma and shorten hospital stays. Around 69% of cardiovascular specialists recommend minimally invasive treatment for suitable patients. Nearly 64% of oncology centers perform embolization and radiofrequency ablation procedures under image guidance for targeted tumor treatment. Image-guided interventions reduce recovery periods by approximately 45% and lower complication rates compared with many conventional surgical procedures. Growing incidence of cardiovascular diseases, cancer, peripheral arterial disease, and chronic liver disorders continues increasing procedural volumes worldwide.

Restraining Factor

High equipment costs and shortage of skilled interventional radiologists.

The Interventional Radiology Market faces challenges related to advanced equipment investment and workforce availability. Approximately 46% of hospitals identify imaging equipment acquisition costs as a significant limitation. Around 41% of healthcare providers report shortages of trained interventional radiologists and specialized clinical staff. Nearly 37% of healthcare institutions experience reimbursement limitations for selected image-guided procedures. Advanced angiography suites require sophisticated imaging equipment, radiation protection systems, and dedicated operating environments. Approximately 34% of smaller hospitals continue referring complex procedures to specialized centers because of limited infrastructure and technical expertise.

Expansion of image-guided oncology and outpatient interventions.

Opportunity

Growing adoption of image-guided cancer treatments presents significant opportunities for the Interventional Radiology Market. Approximately 63% of tertiary oncology hospitals have expanded embolization and tumor ablation services. Around 58% of hospitals continue increasing outpatient interventional radiology programs because minimally invasive procedures reduce hospitalization requirements. Artificial intelligence-assisted imaging has been adopted by approximately 55% of advanced radiology departments to improve procedural planning and diagnostic accuracy. Hybrid operating room installations continue increasing, while approximately 49% of new imaging projects focus on integrating multiple imaging modalities into a single intervention platform for improved clinical outcomes.

Radiation safety requirements and complex regulatory compliance.

Challenge

Maintaining radiation safety while achieving optimal imaging quality remains a significant challenge across the Interventional Radiology Market. Approximately 62% of healthcare facilities continue investing in radiation dose optimization technologies for patients and clinicians. Around 53% of interventional radiology departments conduct routine radiation monitoring and equipment calibration programs. Nearly 44% of healthcare providers identify regulatory compliance and imaging quality assurance as ongoing operational priorities. Continuous staff training, equipment upgrades, and quality control programs are required to maintain safe clinical practices while supporting increasing procedural volumes across cardiovascular, neurological, oncological, and musculoskeletal interventions.

•   
•   
  Download Free Sample to learn more about this report

    

INTERVENTIONAL RADIOLOGY MARKET REGIONAL INSIGHTS

• North America

North America holds approximately 39% of the global Interventional Radiology Market owing to its advanced healthcare infrastructure, widespread adoption of minimally invasive procedures, and high installation of modern imaging systems. The United States contributes nearly 84% of regional demand, while Canada represents approximately 11% and Mexico accounts for 5%. More than 74% of tertiary hospitals operate dedicated interventional radiology departments equipped with digital angiography, CT, fluoroscopy, and ultrasound systems. Approximately 71% of cardiovascular interventions across the region are completed using catheter-based minimally invasive procedures.

The region also leads in technological innovation. Nearly 66% of newly installed angiography systems feature artificial intelligence-assisted image processing, while approximately 59% of hybrid operating rooms integrate multiple imaging modalities for complex procedures. Around 63% of oncology centers perform image-guided embolization and radiofrequency ablation therapies. Outpatient interventional radiology procedures have increased by approximately 38%, supported by shorter recovery periods, improved patient outcomes, and lower complication rates. Growing demand for peripheral vascular interventions, neurovascular procedures, and image-guided biopsies continues strengthening the regional market.

• Europe

Europe accounts for approximately 29% of the Interventional Radiology Market due to strong healthcare systems, increasing elderly population, and widespread availability of advanced diagnostic imaging technologies. Germany contributes approximately 27% of regional demand, followed by France at 18%, the United Kingdom at 16%, Italy at 13%, and Spain at 8%. Nearly 72% of university hospitals maintain dedicated interventional radiology facilities supporting cardiovascular, oncological, neurological, and musculoskeletal procedures.

Approximately 68% of vascular disease treatments in major European hospitals utilize minimally invasive catheter-based interventions. Around 61% of newly installed imaging platforms include three-dimensional visualization and radiation dose reduction technologies. Image-guided oncology procedures continue expanding, with approximately 57% of liver cancer interventions utilizing embolization or thermal ablation therapies. Nearly 53% of healthcare institutions have adopted digital workflow management systems to improve procedural efficiency, patient scheduling, and image archiving. Continued modernization of healthcare infrastructure supports sustained growth throughout the region.

• Asia-Pacific

Asia-Pacific represents approximately 25% of the global Interventional Radiology Market and remains the fastest-expanding regional market because of rapid healthcare development, rising chronic disease prevalence, and increasing investment in advanced imaging systems. China contributes nearly 43% of regional demand, followed by Japan at 20%, India at 16%, South Korea at 10%, and Australia at 5%. Approximately 64% of newly established tertiary hospitals include dedicated interventional radiology suites equipped with digital imaging technologies.

Cardiovascular disease and oncology remain the primary demand drivers. Around 67% of large hospitals perform image-guided vascular interventions, while approximately 59% provide minimally invasive tumor ablation procedures. Government investment in healthcare infrastructure has increased installation of CT scanners, angiography systems, and ultrasound platforms across public hospitals. Approximately 55% of advanced healthcare centers utilize artificial intelligence-assisted imaging for procedural planning. Growing medical tourism, expanding insurance coverage, and increasing physician training programs continue supporting wider adoption of interventional radiology across the region.

• Middle East & Africa

The Middle East & Africa account for approximately 7% of the global Interventional Radiology Market, supported by healthcare modernization and increasing investment in specialized medical services. Saudi Arabia contributes approximately 31% of regional demand, followed by the United Arab Emirates at 19%, South Africa at 17%, Egypt at 10%, and Qatar at 7%. Nearly 58% of tertiary hospitals now operate advanced interventional imaging facilities supporting cardiovascular, oncology, and emergency procedures.

Approximately 54% of newly commissioned hospitals have installed digital angiography and fluoroscopy systems for minimally invasive interventions. Around 49% of major healthcare providers perform image-guided biopsies and vascular embolization procedures. Government healthcare expansion initiatives continue increasing the number of specialized radiology departments and physician training programs. More than 46% of regional hospitals have upgraded imaging equipment to improve diagnostic precision and patient safety. Rising prevalence of cardiovascular disease, cancer, and diabetes continues driving demand for advanced interventional radiology procedures throughout the region.

LIST OF TOP INTERVENTIONAL RADIOLOGY COMPANIES

• Toshiba Medical Systems Corporation
• Siemens AG
• Esaote S.P.A.
• Hitachi Medical Corporation
• Hologic Inc.
• Carestream Health
• Koninklijke Philips N.V.
• Shimadzu Corporation
• GE Healthcare

Top 2 Companies With Highest Market Share

• GE Healthcare: Holds approximately 19% of the global Interventional Radiology Marke.
• Siemens AG: Accounts for approximately 16% of the global Interventional Radiology Market.

INVESTMENT ANALYSIS AND OPPORTUNITIES

The Interventional Radiology Market continues attracting substantial investment due to increasing demand for minimally invasive procedures and advanced diagnostic imaging. Approximately 66% of hospital imaging investments are directed toward upgrading angiography suites, CT scanners, fluoroscopy systems, and hybrid operating rooms. Around 61% of healthcare providers are expanding interventional radiology departments to support growing cardiovascular and oncology procedure volumes. Nearly 58% of tertiary hospitals are investing in artificial intelligence-assisted imaging software to improve workflow efficiency and diagnostic precision.

Hybrid operating room construction continues creating new opportunities, with approximately 47% of newly developed surgical facilities integrating advanced interventional imaging technologies. Around 55% of investment projects focus on digital image management systems, radiation dose optimization, and robotic-assisted navigation. Image-guided oncology services continue expanding, while approximately 53% of healthcare organizations prioritize minimally invasive treatment capabilities. Increasing physician training programs, outpatient intervention centers, and next-generation imaging technologies continue creating significant long-term investment opportunities across developed and emerging healthcare markets.

NEW PRODUCT DEVELOPMENT

Manufacturers continue introducing innovative imaging platforms designed to improve procedural precision, workflow efficiency, and patient safety. Approximately 64% of newly launched angiography systems integrate artificial intelligence for automated image enhancement and lesion detection. Around 59% of advanced fluoroscopy systems feature radiation dose reduction technologies without compromising image quality. High-resolution flat-panel detector technology improves vascular visualization by approximately 24%, enabling greater procedural accuracy.

Robotic-assisted catheter navigation systems are incorporated into approximately 41% of newly introduced interventional radiology platforms. Around 56% of product launches include cloud-based image sharing and digital workflow integration to improve collaboration among multidisciplinary clinical teams. Advanced ultrasound systems provide enhanced Doppler imaging and contrast-enhanced visualization, while next-generation CT scanners deliver faster image acquisition and improved three-dimensional reconstruction. Continuous innovation in biopsy devices, embolization materials, RF ablation systems, and hybrid imaging technologies continues expanding clinical applications and improving patient outcomes across interventional radiology.

FIVE RECENT DEVELOPMENTS (2023-2025)

• 2025: GE Healthcare introduced an advanced AI-enabled Allia image-guided therapy platform featuring automated workflow optimization and enhanced low-dose imaging capabilities.
• 2025: Siemens AG expanded its ARTIS angiography portfolio with improved three-dimensional visualization and artificial intelligence-assisted image reconstruction for complex vascular interventions.
• 2024: Koninklijke Philips N.V. launched enhanced Azurion image-guided therapy software featuring real-time navigation and integrated workflow automation for hybrid operating rooms.
• 2024: Shimadzu Corporation introduced a next-generation angiography system with improved flat-panel detector technology, delivering approximately 24% higher image clarity during minimally invasive procedures.
• 2023: Hologic Inc. expanded its interventional breast biopsy portfolio by introducing upgraded vacuum-assisted biopsy technology with enhanced tissue acquisition efficiency and digital imaging integration.

REPORT COVERAGE OF INTERVENTIONAL RADIOLOGY MARKET

The Interventional Radiology Market report provides comprehensive analysis of market trends, procedure types, imaging technologies, applications, competitive landscape, and regional performance. The report evaluates angiography, balloon angioplasty, embolization, biopsy, vertebroplasty-kyphoplasty, and radiofrequency ablation procedures across cardiovascular, oncology, neurology, orthopedics, and emergency medicine. It analyzes imaging platforms including MRI systems, ultrasound imaging systems, CT scanners, angiography systems, fluoroscopy systems, biopsy devices, and related intervention technologies.

The report profiles 9 major manufacturers while assessing product innovation, technological advancements, healthcare infrastructure development, and competitive positioning. Approximately 78% of vascular procedures globally utilize minimally invasive image-guided techniques, while nearly 66% of newly installed imaging systems integrate artificial intelligence capabilities. The study examines regional market performance across North America, Europe, Asia-Pacific, and the Middle East & Africa, including procedure volumes, technology adoption, investment trends, outpatient care expansion, hybrid operating room development, physician training, regulatory environment, product launches, and strategic opportunities shaping the global Interventional Radiology Market.